CN101750449A - Lipoprotein capillary coating and the preparation method thereof - Google Patents
Lipoprotein capillary coating and the preparation method thereof Download PDFInfo
- Publication number
- CN101750449A CN101750449A CN200810240105A CN200810240105A CN101750449A CN 101750449 A CN101750449 A CN 101750449A CN 200810240105 A CN200810240105 A CN 200810240105A CN 200810240105 A CN200810240105 A CN 200810240105A CN 101750449 A CN101750449 A CN 101750449A
- Authority
- CN
- China
- Prior art keywords
- lipoprotein
- capillary
- coating
- capillary coating
- density lipoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 91
- 239000011248 coating agent Substances 0.000 title claims abstract description 88
- 102000004895 Lipoproteins Human genes 0.000 title claims abstract description 81
- 108090001030 Lipoproteins Proteins 0.000 title claims abstract description 81
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 14
- 239000007822 coupling agent Substances 0.000 claims abstract description 8
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 claims description 29
- 102000007330 LDL Lipoproteins Human genes 0.000 claims description 29
- 108010010234 HDL Lipoproteins Proteins 0.000 claims description 15
- 102000015779 HDL Lipoproteins Human genes 0.000 claims description 15
- 108010062497 VLDL Lipoproteins Proteins 0.000 claims description 15
- 108010004103 Chylomicrons Proteins 0.000 claims description 10
- ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 claims description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000001338 self-assembly Methods 0.000 claims description 6
- 108010071619 Apolipoproteins Proteins 0.000 claims description 5
- 102000007592 Apolipoproteins Human genes 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 239000010453 quartz Substances 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical class CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001840 cholesterol esters Chemical class 0.000 claims 1
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 1
- 238000004375 physisorption Methods 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 19
- 238000001179 sorption measurement Methods 0.000 abstract description 13
- 238000004458 analytical method Methods 0.000 abstract description 10
- 239000000872 buffer Substances 0.000 abstract description 9
- -1 aminopropyl siloxane Chemical class 0.000 abstract description 5
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 abstract description 2
- 125000003277 amino group Chemical group 0.000 abstract description 2
- 230000004071 biological effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 33
- 102000004169 proteins and genes Human genes 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 17
- 238000001962 electrophoresis Methods 0.000 description 14
- 238000005370 electroosmosis Methods 0.000 description 11
- 238000011160 research Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 150000003904 phospholipids Chemical class 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 229920002379 silicone rubber Polymers 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000005251 capillar electrophoresis Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 229920002521 macromolecule Polymers 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000002045 capillary electrochromatography Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004792 oxidative damage Effects 0.000 description 5
- 239000008055 phosphate buffer solution Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000003759 clinical diagnosis Methods 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 230000002427 irreversible effect Effects 0.000 description 4
- 239000004945 silicone rubber Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- DQQXBXSKTVBANA-UHFFFAOYSA-N 1,3-dioxepane-2,4,7-trione Chemical compound O=C1CCC(=O)OC(=O)O1 DQQXBXSKTVBANA-UHFFFAOYSA-N 0.000 description 2
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 230000005183 environmental health Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 108010038061 Chymotrypsinogen Proteins 0.000 description 1
- 102100030497 Cytochrome c Human genes 0.000 description 1
- 108010075031 Cytochromes c Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical group 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 150000002466 imines Chemical group 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明涉及一类脂蛋白毛细管涂层及其制备方法。该涂层可通过物理吸附法和化学键合法制备。物理吸附法是将浓度为0.01-10mg/mL脂蛋白溶液与毛细管内壁发生非共价相互作用,自组装到内表面形成涂层。化学键合法是先采用氨丙基硅氧烷对毛细管进行改性,引入氨基;然后以戊二醛或N,N-琥珀酰氨基碳酸酯或辛二酸二琥珀酰亚胺酯或1-乙基-3-(3-二甲基氨丙基)-碳化二亚胺/N-羟基琥珀酰亚胺为偶联剂,在缓冲液pH(4-9)和脂蛋白浓度(0.1-10mg/mL)条件下,共价连接毛细管壁的氨基与脂蛋白上的氨基酸残基,得脂蛋白涂层。该涂层保留有生物活性,可用于抑制毛细管表面吸附和电渗调控,也可用于生化分离分析。
The invention relates to a lipoprotein capillary coating and a preparation method thereof. The coating can be prepared by physical adsorption and chemical bonding. In the physical adsorption method, a lipoprotein solution with a concentration of 0.01-10 mg/mL interacts non-covalently with the inner wall of the capillary, and self-assembles to the inner surface to form a coating. The chemical bonding method is to first modify the capillary with aminopropyl siloxane and introduce amino groups; -3-(3-Dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide as a coupling agent, at buffer pH (4-9) and lipoprotein concentration (0.1-10mg/mL ) conditions, covalently link the amino acid residues on the capillary wall with the amino acid residues on the lipoprotein to obtain a lipoprotein coating. The coating retains biological activity and can be used to inhibit capillary surface adsorption and electroosmotic regulation, and can also be used for biochemical separation analysis.
Description
技术领域technical field
本发明涉及一类脂蛋白毛细管涂层及其制备方法,适用于毛细管电泳及电色谱法进行生化分离分析、临床诊断和环境污染物毒性分析。The invention relates to a lipoprotein capillary coating and a preparation method thereof, which are suitable for biochemical separation analysis, clinical diagnosis and environmental pollutant toxicity analysis by capillary electrophoresis and electrochromatography.
背景技术Background technique
毛细管电泳(CE)及毛细管电色谱(CEC)技术是将经典的电泳技术与现代微柱色谱分离技术结合的产物,它使分析科学从微升水平进入纳升水平,并使单细胞分析乃至单分子分析成为可能。近年来,随着生命科学和环境健康领域的迅猛发展,毛细管电泳和电色谱技术在生物大分子的分析鉴定(如蛋白质的分离、DNA片段及序列分析等)、临床疾病诊断和临床药物监测、代谢研究、病理研究等方面展现出独特的应用优势,广泛赢得科研工作者的亲睐。Capillary electrophoresis (CE) and capillary electrochromatography (CEC) technologies are the products of the combination of classic electrophoresis technology and modern microcolumn chromatography separation technology. Molecular analysis becomes possible. In recent years, with the rapid development of life sciences and environmental health, capillary electrophoresis and electrochromatography have been widely used in the analysis and identification of biological macromolecules (such as protein separation, DNA fragment and sequence analysis, etc.), clinical disease diagnosis and clinical drug monitoring, Metabolic research, pathological research and other aspects have shown unique application advantages, and have won the favor of scientific researchers.
尽管CE和CEC技术在当前取得了突飞猛进的发展,但是随着科研目的的不断深化以及人们对信息准确性、精确性要求的不断升级,该技术也面临着更为严峻的技术挑战。例如,生物样品或复杂基质在毛细管上的不可逆吸附问题,是进行有关生物大分子研究时经常遇到的关键难点之一。由于生物大分子的不可逆吸附,造成毛细管壁表面zeta电位变化,引起分离效果下降、重现性差、准确度降低等问题,甚至严重时导致生物样品的损失和毛细管损坏。Although CE and CEC technologies have achieved rapid development at present, with the continuous deepening of scientific research purposes and the continuous upgrading of people's requirements for information accuracy and precision, this technology is also facing more severe technical challenges. For example, the irreversible adsorption of biological samples or complex matrices on capillaries is one of the key difficulties often encountered in the study of biological macromolecules. Due to the irreversible adsorption of biological macromolecules, the zeta potential of the capillary wall surface changes, causing problems such as reduced separation effect, poor reproducibility, and reduced accuracy, and even leads to the loss of biological samples and capillary damage in severe cases.
为了克服这一难题,人们提出了一些有效的改善措施,如采用高离子强度的电泳缓冲溶液,选择极端pH条件(pH<2.5或>10),但目前最为普遍接受的是毛细管涂层方案。毛细管涂层技术主要是指采用物理涂敷或化学键合等方法,在毛细管内壁形成一层或多层的涂层材料的方法。按照涂层的制备方法和应用模式,可将毛细管涂层分为动态涂层和永久性涂层。表面活性剂和一些聚合物作为毛细管涂层材料备受关注。然而,大部分报道的方法都会不同程度地引起蛋白质变性或活性损失,成为很多研究中的美中不足。加拿大化学家Lucy等于近年来发展了半永久性的磷酯类涂层,在保证满意的分离效能和稳定性的同时,还实现了良好的生物相容性,为该研究领域注入了新的活力。磷脂是一种具有良好生物相容性的涂层材料,近年来被深入研究和报道。然而,良好的磷脂双层涂层结构的构建高度依赖于涂层条件,譬如自组装形成的磷脂囊泡的尺寸和类型,这大大限制了这种方法的实际应用。In order to overcome this problem, some effective improvement measures have been proposed, such as using high ionic strength electrophoresis buffer solution and selecting extreme pH conditions (pH < 2.5 or > 10), but the most commonly accepted solution is capillary coating. Capillary coating technology mainly refers to the method of forming one or more layers of coating materials on the inner wall of capillary by physical coating or chemical bonding. According to the preparation method and application mode of the coating, capillary coating can be divided into dynamic coating and permanent coating. Surfactants and some polymers have attracted much attention as capillary coating materials. However, most of the reported methods will cause protein denaturation or activity loss to varying degrees, which has become a fly in the ointment in many studies. Canadian chemist Lucy et al. have developed a semi-permanent phospholipid coating in recent years, which not only ensures satisfactory separation performance and stability, but also achieves good biocompatibility, injecting new vitality into this research field. Phospholipid is a coating material with good biocompatibility, which has been intensively studied and reported in recent years. However, the construction of a good phospholipid bilayer coating structure is highly dependent on the coating conditions, such as the size and type of phospholipid vesicles formed by self-assembly, which greatly limits the practical application of this method.
蛋白质是一种天然的内源性、生物相容的生物大分子。将蛋白质作为毛细管涂层材料,除了可以抑制吸附和调控电渗的功能外,还将产生一个新的有应用价值的功用,即用作抗体和药物筛选、临床诊断的测试工具。Protein is a natural endogenous, biocompatible biomacromolecule. Using protein as capillary coating material, in addition to the function of inhibiting adsorption and regulating electroosmosis, will also produce a new and valuable function, that is, it can be used as a test tool for antibody and drug screening and clinical diagnosis.
本发明基于上述目的,以脂蛋白作为涂层材料,分别采用物理自组装和化学键合两种方法制备了具有脂蛋白活性和生物相容性的毛细管涂层。与磷脂双层相比,脂蛋白涂层的构建更为简单、直接、稳定性好,涂层功用也更为广阔。Based on the above purpose, the present invention uses lipoprotein as a coating material to prepare a capillary coating with lipoprotein activity and biocompatibility by means of physical self-assembly and chemical bonding. Compared with the phospholipid bilayer, the construction of the lipoprotein coating is simpler, more direct, and more stable, and the coating has a wider range of functions.
脂蛋白是血液和细胞膜中的一类运输蛋白,主要由脂质体和载脂蛋白组成。由于其结构和密度的差异,常用超速离心法把血浆脂蛋白分为:乳糜微粒(CM),极低密度脂蛋白(VLDL),低密度脂蛋白(LDL),高密度脂蛋白(HDL)。乳糜微粒的功能是转运外源性脂肪;极低密度脂蛋白的功能是转运内源性脂肪;低密度脂蛋白的功能是转运胆固醇;高密度脂蛋白的功能是转运内源性胆固醇和磷脂。脂蛋白的功能和其结构密切相关。大部分脂蛋白是由磷脂、载脂蛋白(如Apo B和Apo E等)、胆固醇和胆固醇脂等构成。以低密度脂蛋白为例,分布在分子表面的磷脂和载脂蛋白(Apo B)在结构组成中各占1/4的比重。Lipoproteins are a class of transport proteins in blood and cell membranes, mainly composed of liposomes and apolipoproteins. Due to the difference in structure and density, plasma lipoproteins are commonly divided into chylomicrons (CM), very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) by ultracentrifugation. The function of chylomicrons is to transport exogenous fat; the function of very low density lipoprotein is to transport endogenous fat; the function of low density lipoprotein is to transport cholesterol; the function of high density lipoprotein is to transport endogenous cholesterol and phospholipids. The function of lipoprotein is closely related to its structure. Most lipoproteins are composed of phospholipids, apolipoproteins (such as Apo B and Apo E, etc.), cholesterol and cholesteryl lipids. Taking low-density lipoprotein as an example, phospholipids and apolipoprotein (Apo B) distributed on the surface of the molecule each account for 1/4 of the structural composition.
因此,本发明将不同的脂蛋白固定到毛细管上,既可以有效地抑制由硅羟基带来的不可逆吸附,又可进行与脂蛋白功能相关的应用研究。通过实验,初步表明脂蛋白涂层在蛋白质生化分离分析、环境污染物体内运输机制和自由基致蛋白损伤方面具有一定应用价值。相应地,认为在临床诊断、抗体和药物筛选、环境健康效应研究等方面也将具有良好的应用前景。Therefore, the present invention immobilizes different lipoproteins on the capillary, which can not only effectively inhibit the irreversible adsorption caused by silanol, but also carry out applied research related to lipoprotein functions. Through experiments, it is preliminarily shown that the lipoprotein coating has certain application value in the biochemical separation and analysis of proteins, the transport mechanism of environmental pollutants in vivo and the protein damage caused by free radicals. Correspondingly, it is believed that it will also have good application prospects in clinical diagnosis, antibody and drug screening, and environmental health effect research.
发明内容Contents of the invention
本发明涉及一类脂蛋白毛细管涂层及其制备方法,其目的在于研制出一种大分子涂层,并保留一定生物活性和生物相容性,使之既可用于毛细管表面吸附的抑制和电渗调控,又可以用于生化分析和临床检测等具体应用。脂蛋白包括极低密度脂蛋白、低密度脂蛋白、高密度脂蛋白和乳糜微粒。The present invention relates to a kind of lipoprotein capillary coating and its preparation method, and its purpose is to develop a kind of macromolecule coating, and retain certain biological activity and biocompatibility, make it can be used for the suppression of the capillary surface adsorption and the electric charge It can also be used in specific applications such as biochemical analysis and clinical detection. Lipoproteins include very low-density lipoproteins, low-density lipoproteins, high-density lipoproteins, and chylomicrons.
本发明的另一目的在于提供上述脂蛋白涂层的制备方法,该方法操作简单,易于保持脂蛋白的活性和稳定性。Another object of the present invention is to provide a method for preparing the lipoprotein coating, which is simple to operate and easy to maintain the activity and stability of the lipoprotein.
本发明所涉及的脂蛋白毛细管涂层的制备可以通过两种方法实现,即物理吸附法(或称自组装法)和化学键合法。The preparation of the lipoprotein capillary coating involved in the present invention can be realized by two methods, namely physical adsorption method (or called self-assembly method) and chemical bonding method.
物理吸附法(自组装法)制备脂蛋白毛细管涂层的原理:在一定浓度的缓冲溶液(0.1-100mM,pH 4-9)和温度(4-37℃)条件下,使脂蛋白(浓度0.01-10mg/mL)与石英或玻璃毛细管内壁的硅羟基发生疏水、静电吸引等非共价相互作用,从而自组装到内壁表面形成结合层;然后用缓冲液洗去未结合的脂蛋白,制得脂蛋白毛细管涂层。The principle of preparing lipoprotein capillary coating by physical adsorption method (self-assembly method): under the conditions of a certain concentration of buffer solution (0.1-100mM, pH 4-9) and temperature (4-37°C), lipoprotein (concentration 0.01 -10mg/mL) has non-covalent interactions such as hydrophobic and electrostatic attraction with the silanol on the inner wall of the quartz or glass capillary, thereby self-assembling to the surface of the inner wall to form a binding layer; Lipoprotein capillary coating.
化学键合法制备脂蛋白毛细管涂层的原理:先依据溶胶-凝胶技术,用γ-氨丙基三乙氧基硅烷或γ-氨丙基三甲氧基硅烷等硅烷化试剂对毛细管进行改性,引入氨基活性基团,制得氨基修饰的毛细管;然后以过量的戊二醛或N,N-琥珀酰氨基碳酸酯(DSC)或辛二酸二琥珀酰亚胺酯(DSS)或1-乙基-3-(3-二甲基氨丙基)-碳化二亚胺/N-羟基琥珀酰亚胺体系(EDC/NHS)为偶联剂,在一定缓冲溶液pH值(pH 4-9)、温度(4-37℃)以及脂蛋白浓度(0.1-10mg/mL)的条件下,共价连接毛细管上的氨基与脂蛋白上的氨基酸残基,将脂蛋白固定到毛细管内壁;最后用缓冲液洗去未结合的脂蛋白,制得脂蛋白毛细管涂层。The principle of preparing lipoprotein capillary coating by chemical bonding: firstly, according to the sol-gel technique, the capillary is modified with silylating reagents such as γ-aminopropyltriethoxysilane or γ-aminopropyltrimethoxysilane, Amino active groups are introduced to prepare amino-modified capillaries; then excess glutaraldehyde or N, N-succinyl carbonate (DSC) or disuccinimidyl suberate (DSS) or 1-ethane Base-3-(3-dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide system (EDC/NHS) as coupling agent, in a certain buffer solution pH value (pH 4-9) , temperature (4-37°C) and lipoprotein concentration (0.1-10mg/mL), covalently link the amino group on the capillary to the amino acid residue on the lipoprotein, and fix the lipoprotein to the inner wall of the capillary; finally use buffer The unbound lipoproteins were washed away with liquid to obtain lipoprotein capillary coatings.
本发明所涉及的脂蛋白毛细管涂层及制备方法具有以下几个特点:具有良好的生物相容性,适用于生物大分子的分离和分析;保留脂蛋白的活性,可模拟生物膜进行其与生物大分子、小分子之间的相互作用研究,可用于临床诊断和药理研究;可根据脂蛋白的等电点(pI5-6),通过选择电泳缓冲液来对电渗进行调控;具有磷脂和载脂蛋白等活性组份,可为药物载体的设计和外源性物质体内运输过程的机制提供研究工具。The lipoprotein capillary coating and preparation method involved in the present invention have the following characteristics: good biocompatibility, suitable for the separation and analysis of biological macromolecules; retaining the activity of lipoproteins, and can simulate biomembrane for its interaction with The research on the interaction between biological macromolecules and small molecules can be used in clinical diagnosis and pharmacological research; according to the isoelectric point (pI5-6) of lipoproteins, the electrophoresis buffer can be selected to regulate electrophoresis; with phospholipids and Active components such as apolipoproteins can provide research tools for the design of drug carriers and the mechanism of exogenous substances in vivo transport process.
附图说明Description of drawings
图1为化学键合法制备脂蛋白涂层的合成路线示意图。Fig. 1 is a schematic diagram of the synthesis route of lipoprotein coating prepared by chemical bonding method.
图2为缓冲液pH与低密度脂蛋白涂层产生电渗的关系图。Figure 2 is a graph showing the relationship between the pH of the buffer and the electroosmosis produced by the low-density lipoprotein coating.
图3为脂蛋白毛细管涂层用于蛋白质的分离色谱图。Figure 3 is a chromatogram of a lipoprotein capillary coating used for protein separation.
具体实施方式Detailed ways
脂蛋白毛细管涂层及其制备方法,用以下实施方案举例说明。Lipoprotein capillary coatings and methods for their preparation are exemplified by the following embodiments.
在制备脂蛋白涂层之前,首先要进行毛细管的预处理。毛细管先用色谱纯甲醇冲洗1小时,然后用1mol/L氢氧化钠冲洗1-2小时,去离子水清洗毛细管15分钟,再用1mol/L盐酸冲洗1-2小时,最后用去离子水冲洗15分钟,高纯氮气吹干备用。预处理完成后,进行脂蛋白涂层的制备。Before preparing the lipoprotein coating, the capillary should be pretreated first. Wash the capillary with chromatographically pure methanol for 1 hour, then wash it with 1mol/L sodium hydroxide for 1-2 hours, wash the capillary with deionized water for 15 minutes, then wash it with 1mol/L hydrochloric acid for 1-2 hours, and finally wash it with deionized water After 15 minutes, blow dry with high-purity nitrogen for later use. After the pretreatment is completed, the preparation of the lipoprotein coating is carried out.
实施例1物理吸附法制备低密度脂蛋白毛细管涂层Embodiment 1 physical adsorption method prepares low-density lipoprotein capillary coating
称取5.0mg的低密度脂蛋白冻干粉,充分溶解于5.0mL的25mmoL磷酸盐缓冲溶液(pH=7.4)中,配制成1.0mg/mL的涂层溶液。将该涂层溶液在10psi压力下通过经预处理的毛细管15分钟,然后用硅橡胶封住毛细管两端,毛细管内灌注有上述低密度脂蛋白涂层溶液,于室温下静置2-4小时。再次灌装涂层溶液,封住毛细管两端,于室温下静置2小时以上。完成上述操作后,用25mmoL磷酸盐缓冲溶液(pH=7.4)冲洗毛细管30分钟,去除未与管壁结合的低密度脂蛋白,毛细管两端用硅橡胶密封,并置于冰箱内4℃保存。Weigh 5.0 mg of low-density lipoprotein freeze-dried powder, fully dissolve in 5.0 mL of 25 mmoL phosphate buffer solution (pH=7.4), and prepare a coating solution of 1.0 mg/mL. Pass the coating solution through the pretreated capillary under 10psi pressure for 15 minutes, then seal both ends of the capillary with silicone rubber, fill the capillary with the above-mentioned low-density lipoprotein coating solution, and let it stand at room temperature for 2-4 hours . Fill the coating solution again, seal both ends of the capillary, and let it stand at room temperature for more than 2 hours. After completing the above operations, rinse the capillary with 25mmoL phosphate buffer solution (pH=7.4) for 30 minutes to remove the low-density lipoprotein not bound to the tube wall, seal both ends of the capillary with silicone rubber, and store in a refrigerator at 4°C.
高密度脂蛋白、极低密度脂蛋白、乳糜微粒以及混合脂蛋白涂层合成方案与上述操作相同,仅需将低密度脂蛋白涂层溶液替换成相应的脂蛋白溶液。The synthesis scheme of high-density lipoprotein, very low-density lipoprotein, chylomicron and mixed lipoprotein coating is the same as the above operation, only the low-density lipoprotein coating solution needs to be replaced with the corresponding lipoprotein solution.
实施例2氨丙基修饰的毛细管的制备The preparation of the capillary of embodiment 2 aminopropyl modifications
移取0.1mL的γ-氨丙基三甲氧基硅烷,溶于1.0mL的水(稀醋酸调pH 5)-甲醇(2∶8,体积比)的混合溶液中,充分混匀后迅速充入预处理的毛细管中,将毛细管两端用硅橡胶密封,室温下反应2-4小时。反应完成后,依次用甲醇、水冲洗毛细管各30分钟,然后毛细管在高纯氮气保护下,置于105-120℃的烘箱内陈化干燥2小时以上。通过上述处理步骤,得到氨丙基修饰的毛细管。Pipette 0.1mL of γ-aminopropyltrimethoxysilane, dissolve it in 1.0mL of water (dilute acetic acid to adjust pH 5)-methanol (2:8, volume ratio) mixed solution, mix well and quickly fill into In the pretreated capillary, seal both ends of the capillary with silicon rubber, and react at room temperature for 2-4 hours. After the reaction is completed, the capillary is washed with methanol and water for 30 minutes each, and then the capillary is aged and dried in an oven at 105-120° C. for more than 2 hours under the protection of high-purity nitrogen. Aminopropyl-modified capillaries were obtained through the above-mentioned treatment steps.
实施例3以戊二醛为偶联剂的化学键合法制备低密度脂蛋白毛细管涂层Embodiment 3 uses glutaraldehyde as the chemical bonding method of coupling agent to prepare low-density lipoprotein capillary coating
移取0.5mL 50%的戊二醛水溶液,加入到4.5mL的25mmoL磷酸盐缓冲溶液(pH=7.4)中,充分混匀后,在5psi的压力下充入由实施例2制备的氨丙基修饰毛细管,1小时后用硅橡胶密封毛细管两端,静置于室温反应2-6小时。然后用25mmoL磷酸盐缓冲溶液(pH=7.4)将反应未尽的戊二醛溶液冲出,得到戊二醛修饰的毛细管。Pipette 0.5mL of 50% glutaraldehyde aqueous solution, join in the 25mmoL phosphate buffered saline solution (pH=7.4) of 4.5mL, after fully mixing, fill in by the aminopropyl group prepared by embodiment 2 under the pressure of 5psi After modifying the capillary, seal both ends of the capillary with silicone rubber after 1 hour, and let it stand at room temperature for 2-6 hours. Then, 25 mmoL phosphate buffer solution (pH=7.4) was used to flush out the unreacted glutaraldehyde solution to obtain a glutaraldehyde-modified capillary.
按照实施例1所述方法配制1.0mg/mL的低密度脂蛋白涂层溶液,将该溶液充入上述经戊二醛处理过的毛细管中,30分钟后封住两端,于室温下继续反应2-4小时。在此反应过程中,脂蛋白与戊二醛的醛基发生共价作用,生成希夫碱式化合物。用磷酸盐缓冲溶液将反应未尽的脂蛋白涂层溶液冲出,再用浓度为0.5mg/mL的氰基硼氢化钠溶液(在25mmoL磷酸盐缓冲液中,pH 6.4)冲洗20分钟。用硅橡胶密封毛细管两端,于室温下继续反应4-8小时,将不稳定的希夫碱结构还原成较稳定的亚胺结构(见附图1)。最后用25mmoL磷酸盐缓冲溶液(pH=7.4)将反应液冲出,得到低密度脂蛋白的毛细管涂层。如不立即使用,须置于冰箱4℃保存。Prepare a 1.0 mg/mL low-density lipoprotein coating solution according to the method described in Example 1, fill the solution into the above-mentioned capillary treated with glutaraldehyde, seal both ends after 30 minutes, and continue the reaction at room temperature 2-4 hours. During this reaction, lipoproteins covalently interact with the aldehyde groups of glutaraldehyde to form Schiff base compounds. The unreacted lipoprotein coating solution was flushed out with phosphate buffer solution, and then washed with 0.5 mg/mL sodium cyanoborohydride solution (in 25 mmoL phosphate buffer, pH 6.4) for 20 minutes. Seal both ends of the capillary with silicon rubber, and continue to react at room temperature for 4-8 hours to reduce the unstable Schiff base structure to a relatively stable imine structure (see accompanying drawing 1). Finally, the reaction solution was flushed out with 25 mmoL phosphate buffer solution (pH=7.4) to obtain a capillary coating of low-density lipoprotein. If not used immediately, store in refrigerator at 4°C.
高密度脂蛋白、极低密度脂蛋白、乳糜微粒以及混合脂蛋白涂层合成方案与上述操作相同,仅需将低密度脂蛋白涂层溶液替换成相应的脂蛋白溶液。The synthesis scheme of high-density lipoprotein, very low-density lipoprotein, chylomicron and mixed lipoprotein coating is the same as the above operation, only the low-density lipoprotein coating solution needs to be replaced with the corresponding lipoprotein solution.
实施例4以N,N-琥珀酰氨基碳酸酯(DSC)为偶联剂制备高密度脂蛋白毛细管涂层Example 4 Preparation of high-density lipoprotein capillary coating with N, N-succinylaminocarbonate (DSC) as coupling agent
称取5.0mg的DSC溶于5mL乙腈中,充分混匀。将上述溶液充入由实施例2制备的氨丙基修饰毛细管中,20分钟后用硅橡胶密封毛细管两端,并置于45℃水浴中反应2-4小时。待反应完成后,依次用乙腈、去离子水和25mmoL磷酸盐缓冲液(pH 7.4)冲洗毛细管10分钟。Weigh 5.0 mg of DSC and dissolve it in 5 mL of acetonitrile, and mix well. Fill the above solution into the aminopropyl-modified capillary prepared in Example 2, seal both ends of the capillary with silicon rubber after 20 minutes, and place it in a 45° C. water bath for 2-4 hours to react. After the reaction was completed, the capillary was rinsed with acetonitrile, deionized water, and 25 mmoL phosphate buffer (pH 7.4) for 10 minutes.
按照实施例1所述方法配制1.0mg/mL的高密度脂蛋白涂层溶液,将该溶液充入上述经DSC处理过的毛细管中,于室温下反应2-4小时。待反应完成后,用25mmoL磷酸盐缓冲液(pH 7.4)冲洗毛细管30分钟,得到高密度脂蛋白的毛细管涂层(见附图1)。如不立即使用,须置于冰箱4℃保存。According to the method described in Example 1, a 1.0 mg/mL high-density lipoprotein coating solution was prepared, and the solution was filled into the above-mentioned DSC-treated capillary, and reacted at room temperature for 2-4 hours. After the reaction was completed, the capillary was rinsed with 25mmoL phosphate buffer (pH 7.4) for 30 minutes to obtain a capillary coating of high-density lipoprotein (see Figure 1). If not used immediately, store in refrigerator at 4°C.
低密度脂蛋白、极低密度脂蛋白、乳糜微粒以及混合脂蛋白涂层合成方案与上述操作相同,仅需将高密度脂蛋白涂层溶液替换成相应的脂蛋白溶液。The synthesis scheme of low-density lipoprotein, very low-density lipoprotein, chylomicron and mixed lipoprotein coating is the same as above, only the high-density lipoprotein coating solution needs to be replaced with the corresponding lipoprotein solution.
实施例5以辛二酸二琥珀酰亚胺酯(DSS)为偶联剂制备高密度脂蛋白毛细管涂层Example 5 Preparation of high-density lipoprotein capillary coating with disuccinimidyl suberate (DSS) as coupling agent
以DSS为偶联剂制备极低密度脂蛋白毛细管涂层的操作与实施例4相同,仅须将N,N-琥珀酰氨基碳酸酯更换为DSS(见附图1)。The operation of using DSS as the coupling agent to prepare the VLDL capillary coating is the same as in Example 4, except that N, N-succinylaminocarbonate is replaced by DSS (see Figure 1).
低密度脂蛋白、极低密度脂蛋白、乳糜微粒以及混合脂蛋白涂层合成方案与上述操作相同,仅需将高密度脂蛋白涂层溶液替换成相应的脂蛋白溶液。The synthesis scheme of low-density lipoprotein, very low-density lipoprotein, chylomicron and mixed lipoprotein coating is the same as above, only the high-density lipoprotein coating solution needs to be replaced with the corresponding lipoprotein solution.
实施例6以EDC/NHS为偶联剂的化学键合法制备极低密度脂蛋白毛细管涂层Example 6 Preparation of very low-density lipoprotein capillary coating by chemical bonding using EDC/NHS as coupling agent
称取5.0mg的极低密度脂蛋白,溶于5mL的25mmoL磷酸盐缓冲液(pH 6.0)中;向该溶液中依次加入2.0mg EDC和3.0mg NHS,室温下漩涡震荡5分钟,静置25分钟。将上述溶液充入由实施例2制备的氨丙基修饰毛细管中,15分钟后用硅橡胶密封毛细管两端,4℃-25℃反应4小时以上。待反应完成后,用25mmoL磷酸盐缓冲液(pH 7.4)冲洗毛细管30分钟,得到极低密度脂蛋白的毛细管涂层(见附图1)。Weigh 5.0 mg of very low-density lipoprotein and dissolve it in 5 mL of 25 mmoL phosphate buffer (pH 6.0); add 2.0 mg of EDC and 3.0 mg of NHS to the solution in turn, vortex for 5 minutes at room temperature, and let stand for 25 minute. Fill the above solution into the aminopropyl-modified capillary prepared in Example 2, seal both ends of the capillary with silicone rubber after 15 minutes, and react at 4°C-25°C for more than 4 hours. After the reaction was completed, the capillary was rinsed with 25mmoL phosphate buffer (pH 7.4) for 30 minutes to obtain a capillary coating of very low-density lipoprotein (see Figure 1).
高密度脂蛋白、低密度脂蛋白、乳糜微粒以及混合脂蛋白涂层合成方案与上述操作相同,仅需将极低密度脂蛋白涂层溶液替换成相应的脂蛋白溶液。The synthesis scheme of high-density lipoprotein, low-density lipoprotein, chylomicron and mixed lipoprotein coating is the same as the above operation, only the very low-density lipoprotein coating solution needs to be replaced with the corresponding lipoprotein solution.
实施例7脂蛋白毛细管涂层对于电渗的控制
由实施例1制备的物理吸附(自组装)型脂蛋白毛细管涂层与实施例3-5制备的化学键合型脂蛋白毛细管涂层有相近的电渗控制行为。通过上述实施方案制备的脂蛋白毛细管涂层,可根据使用电泳缓冲液的不同实现对电渗的控制。电渗淌度的计算公式为:The physically adsorbed (self-assembled) lipoprotein capillary coating prepared in Example 1 has similar electroosmotic control behavior to the chemically bonded lipoprotein capillary coating prepared in Examples 3-5. The lipoprotein capillary coating prepared in the above embodiments can realize the control of electroosmosis according to the different electrophoresis buffers used. The formula for calculating electroosmotic mobility is:
电渗(cm2/Vs)=毛细管总长(cm)×有效长度(cm)/[电压(V)×迁移时间(s)]Electroosmosis (cm 2 /Vs) = total capillary length (cm) × effective length (cm) / [voltage (V) × migration time (s)]
以物理吸附型和化学键合型低密度脂蛋白涂层为例,选定实验条件为:涂层毛细管内径50μm,总长50cm,有效长度40cm,施加电压15kV,以N,N′-二甲基甲酰胺(DMF)为电渗标记物,进样压力0.5psi,进样时间5秒。在此条件下,如果将电泳缓冲液(25mmoL磷酸盐缓冲液)pH值从4逐渐改变到pH 8时,电渗淌度将会发生方向和绝对值大小的改变(见附图2)。并且,线性拟合曲线与X轴(pH值)的交点在5.3-5.5之间,与低密度脂蛋白的等电点(pI约为5.5)接近。Taking physical adsorption and chemical bonding low-density lipoprotein coatings as examples, the selected experimental conditions are: the inner diameter of the coating capillary is 50 μm, the total length is 50 cm, the effective length is 40 cm, and the applied voltage is 15 kV. Amide (DMF) is an electroosmotic marker, the injection pressure is 0.5 psi, and the injection time is 5 seconds. Under these conditions, if the pH value of the electrophoresis buffer (25mmoL phosphate buffer) is gradually changed from 4 to pH 8, the direction and absolute value of the electroosmotic mobility will change (see accompanying drawing 2). Moreover, the intersection point of the linear fitting curve and the X-axis (pH value) is between 5.3-5.5, which is close to the isoelectric point of low-density lipoprotein (pI is about 5.5).
实验结果验证了脂蛋白毛细管涂层对电渗的可控性。这一特点可以为不同的分析及分离目的提供灵活简便的操作参数,从而提高分离效率和分析速度。The experimental results verified the controllability of lipoprotein capillary coating on electroosmosis. This feature can provide flexible and simple operating parameters for different analysis and separation purposes, thereby improving separation efficiency and analysis speed.
实施例8脂蛋白毛细管涂层用于蛋白质的生化分离和分析Example 8 Lipoprotein capillary coating is used for biochemical separation and analysis of proteins
采用化学键合法制备的低密度脂蛋白涂层,对细胞色素c(Cyt c)、溶菌酶(Lys)、核糖核酸酶A(RNase A)和α-糜蛋白酶原A(α-Chy A)4种碱性蛋白进行了分离。电泳条件:毛细管内径50μm,总长50cm,有效长度40cm,施加电压+15kV,以25mmoL磷酸盐溶液(pH 7.4)为电泳缓冲液,混合样品中各蛋白质浓度0.2mg/mL,进样压力0.5psi,进样时间5秒。结果表明,在上述电泳条件下,以上4种碱性蛋白质达到完全电泳分离,分离度大于1.5(见附图3)。蛋白质的分离效率为8700-124000块理论塔板/米,回收率在82%-96%之间,日间和日内精密度相对标准偏差(RSD)为1.2%-5.7%(见表1),满足上述碱性蛋白质生化分离以及定性定量分析的要求。The low-density lipoprotein coating prepared by chemical bonding is effective for four kinds of cytochrome c (Cyt c), lysozyme (Lys), ribonuclease A (RNase A) and α-chymotrypsinogen A (α-Chy A) Basic proteins were separated. Electrophoresis conditions: capillary inner diameter 50μm, total length 50cm, effective length 40cm, applied voltage +15kV, 25mmoL phosphate solution (pH 7.4) as electrophoresis buffer, protein concentration in the mixed sample 0.2mg/mL, injection pressure 0.5psi, The injection time is 5 seconds. The results showed that under the above electrophoresis conditions, the above four basic proteins were completely separated by electrophoresis, and the separation degree was greater than 1.5 (see accompanying drawing 3). The separation efficiency of protein is 8700-124000 theoretical plates/meter, and the rate of recovery is between 82%-96%, and the relative standard deviation (RSD) of precision between day and day is 1.2%-5.7% (see Table 1), Meet the requirements of the above basic protein biochemical separation and qualitative and quantitative analysis.
脂蛋白涂层与分析物之间除存在疏水和静电相互作用外,还可能存在一定的亲和作用。脂蛋白涂层具有良好的结构特征及生物相容性,可以抑制蛋白质等生物大分子在毛细管壁上的不可逆吸附,适用于蛋白质的生化分离和分析。In addition to hydrophobic and electrostatic interactions, there may also be a certain affinity between the lipoprotein coating and the analyte. Lipoprotein coating has good structural characteristics and biocompatibility, can inhibit the irreversible adsorption of protein and other biomacromolecules on the capillary wall, and is suitable for biochemical separation and analysis of proteins.
表1低密度脂蛋白毛细管涂层电泳分离蛋白质的性能Table 1 Properties of proteins separated by low-density lipoprotein capillary coating electrophoresis
实施例9低密度脂蛋白毛细管涂层用于自由基氧化损伤机理的研究Example 9 Low Density Lipoprotein Capillary Coating Used in Research on the Mechanism of Free Radical Oxidative Damage
采用低密度脂蛋白涂层毛细管,研究二价铜离子(Cu2+)诱导低密度脂蛋白的自由基氧化损伤。电泳条件:毛细管内径50μm,总长50cm,有效长度40cm,施加电压+15kV,以25mmoL磷酸盐溶液(pH 7.4)为电泳缓冲液,以0.2%DMF为电渗标记物,混合样品中各蛋白质浓度0.2mg/mL,进样压力0.5psi,进样时间5秒。CuSO4溶液的配制:称取8.0mg(50μmol)的无水硫酸铜,溶于10mL的25mmoL磷酸盐缓冲液(pH 7.4)中,配制成5μmol的CuSO4溶液。低密度脂蛋白涂层的氧化修饰:将上述CuSO4溶液分别冲入3支尺寸相同的低密度脂蛋白涂层毛细管内,密封两端,置于37℃水浴分别孵育2、6和12小时。反应完成后,用电泳缓冲液将管内溶液冲出,并继续冲洗20-30分钟,最后接入毛细管电泳仪进行电渗测定和蛋白质分离。The low-density lipoprotein-coated capillary was used to study the free radical oxidative damage of low-density lipoprotein induced by divalent copper ions (Cu 2+ ). Electrophoresis conditions: capillary inner diameter 50 μm, total length 50 cm,
按照实施例7所述方法测定电渗,按照实施例8所述方法进行蛋白质分离。脂蛋白的折合氧化率用电渗流的相对变化表示,即[(Cu2+氧化后的电渗-未氧化电渗)/未氧化电渗]×100%。结果表明,二价铜离子(Cu2+)可以诱导低密度脂蛋白的自由基氧化损伤,而且随着处理时间的增长折合氧化率也随之增加,脂蛋白涂层的稳定性下降,对蛋白质分离的效率也显著降低(见表2)。Electroosmosis was measured according to the method described in Example 7, and protein separation was performed according to the method described in Example 8. The reduced oxidation rate of lipoprotein is expressed by the relative change of electroosmotic flow, that is, [(electroosmosis after oxidation of Cu 2+ - electroosmosis without oxidation)/electroosmosis without oxidation]×100%. The results show that divalent copper ions (Cu 2+ ) can induce free radical oxidative damage to low-density lipoprotein, and the equivalent oxidation rate increases with the increase of treatment time, the stability of lipoprotein coating decreases, and the protein The efficiency of the separation was also significantly reduced (see Table 2).
脂蛋白的氧化修饰是引发动脉粥状硬化的主要诱因之一,自由基的存在会促进脂蛋白的氧化损伤。利用脂蛋白毛细管涂层可进行脂蛋白自由基氧化损伤以及动脉粥状硬化致病机理的研究。The oxidative modification of lipoprotein is one of the main causes of atherosclerosis, and the existence of free radicals will promote the oxidative damage of lipoprotein. Lipoprotein capillary coating can be used to study the oxidative damage of lipoprotein free radicals and the pathogenesis of atherosclerosis.
表2Cu2+导致的涂层性能变化与脂蛋白的自由基氧化之间的关系Table 2 Relationship between changes in coating properties caused by Cu 2+ and free radical oxidation of lipoproteins
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810240105A CN101750449A (en) | 2008-12-18 | 2008-12-18 | Lipoprotein capillary coating and the preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810240105A CN101750449A (en) | 2008-12-18 | 2008-12-18 | Lipoprotein capillary coating and the preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101750449A true CN101750449A (en) | 2010-06-23 |
Family
ID=42477745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810240105A Pending CN101750449A (en) | 2008-12-18 | 2008-12-18 | Lipoprotein capillary coating and the preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101750449A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103091385A (en) * | 2013-02-05 | 2013-05-08 | 中央民族大学 | Capillary enzyme array micro-reactor and its application |
CN103808786A (en) * | 2014-02-27 | 2014-05-21 | 福州大学 | Method for preparing capillary coating for inhibiting protein adsorption |
CN104294236A (en) * | 2013-07-19 | 2015-01-21 | 安捷伦科技有限公司 | Metal components with inert vapor phase coating on internal surfaces |
CN103623795B (en) * | 2013-12-06 | 2015-06-10 | 武汉大学 | Preparation method for open tubular capillary based on metal-organic framework material |
CN109406608A (en) * | 2018-12-20 | 2019-03-01 | 兰州大学 | The method and application of Dynamic coating are carried out to capillary using humoral sample solution to be measured |
CN109444409A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of chemiluminescence immune detection reagent kit of canine distemper virus antibody |
CN109444411A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of canine parvovirus antibody chemical luminescence immue quantitative detection reagent box |
CN109444420A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of chemical luminescence immune analysis reagent box quantitative determining cat serum amyloid A protein |
CN109444419A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of chemical luminescence immune analysis reagent box detecting dog thyrotropic hormone |
CN109716122A (en) * | 2016-08-15 | 2019-05-03 | 塔斯马尼亚大学 | Inorganic ions detection system and method |
CN106771226B (en) * | 2016-11-10 | 2019-10-08 | 中国科学院成都生物研究所 | A kind of bovine serum albumin(BSA) detection probe and its preparation method and application based on capillary glass tube |
CN110361532A (en) * | 2019-07-04 | 2019-10-22 | 山东师范大学 | It is a kind of based on the immunochromatography capillary of colloidal gold photo-thermal effect and its application |
US10767259B2 (en) | 2013-07-19 | 2020-09-08 | Agilent Technologies, Inc. | Components with an atomic layer deposition coating and methods of producing the same |
-
2008
- 2008-12-18 CN CN200810240105A patent/CN101750449A/en active Pending
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103091385B (en) * | 2013-02-05 | 2015-07-08 | 中央民族大学 | Capillary enzyme array micro-reactor and its application |
CN103091385A (en) * | 2013-02-05 | 2013-05-08 | 中央民族大学 | Capillary enzyme array micro-reactor and its application |
CN104294236A (en) * | 2013-07-19 | 2015-01-21 | 安捷伦科技有限公司 | Metal components with inert vapor phase coating on internal surfaces |
US10895009B2 (en) | 2013-07-19 | 2021-01-19 | Agilent Technologies, Inc. | Metal components with inert vapor phase coating on internal surfaces |
US10767259B2 (en) | 2013-07-19 | 2020-09-08 | Agilent Technologies, Inc. | Components with an atomic layer deposition coating and methods of producing the same |
CN103623795B (en) * | 2013-12-06 | 2015-06-10 | 武汉大学 | Preparation method for open tubular capillary based on metal-organic framework material |
CN103808786A (en) * | 2014-02-27 | 2014-05-21 | 福州大学 | Method for preparing capillary coating for inhibiting protein adsorption |
CN109716122A (en) * | 2016-08-15 | 2019-05-03 | 塔斯马尼亚大学 | Inorganic ions detection system and method |
CN109716122B (en) * | 2016-08-15 | 2022-06-24 | 塔斯马尼亚大学 | Inorganic ion detection system and method |
CN106771226B (en) * | 2016-11-10 | 2019-10-08 | 中国科学院成都生物研究所 | A kind of bovine serum albumin(BSA) detection probe and its preparation method and application based on capillary glass tube |
CN109444420A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of chemical luminescence immune analysis reagent box quantitative determining cat serum amyloid A protein |
CN109444419A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of chemical luminescence immune analysis reagent box detecting dog thyrotropic hormone |
CN109444411A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of canine parvovirus antibody chemical luminescence immue quantitative detection reagent box |
CN109444409A (en) * | 2018-10-26 | 2019-03-08 | 成都普利泰生物科技有限公司 | A kind of chemiluminescence immune detection reagent kit of canine distemper virus antibody |
CN109406608A (en) * | 2018-12-20 | 2019-03-01 | 兰州大学 | The method and application of Dynamic coating are carried out to capillary using humoral sample solution to be measured |
CN110361532A (en) * | 2019-07-04 | 2019-10-22 | 山东师范大学 | It is a kind of based on the immunochromatography capillary of colloidal gold photo-thermal effect and its application |
CN110361532B (en) * | 2019-07-04 | 2023-08-04 | 山东师范大学 | An immunochromatographic capillary based on colloidal gold photothermal effect and its application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101750449A (en) | Lipoprotein capillary coating and the preparation method thereof | |
Kostal et al. | Capillary electrophoresis in bioanalysis | |
Bi et al. | Click synthesis of hydrophilic maltose-functionalized iron oxide magnetic nanoparticles based on dopamine anchors for highly selective enrichment of glycopeptides | |
Reed et al. | Properties of the tetrodotoxin binding component in plasma membranes isolated from Electrophorus electricus | |
Capriotti et al. | Liposome protein corona characterization as a new approach in nanomedicine | |
EP2174908B1 (en) | Device and use thereof | |
Pappas et al. | Recent advances in micellar electrokinetic chromatography | |
Breyton et al. | Amphipols and fluorinated surfactants: two alternatives to detergents for studying membrane proteins in vitro | |
Schmalzing et al. | Capillary electrophoresis‐based immunoassays | |
US20090033002A1 (en) | Methods and apparatus for improving the sensitivity of capillary zone electrophoresis | |
CN108927116A (en) | A kind of preparation method for the stannic oxide/graphene nano material that phenyl boric acid functionalization is chitosan-modified | |
Lipponen et al. | Capillary electrochromatography and quartz crystal microbalance, valuable techniques in the study of heparin–lipoprotein interactions | |
Pichon | Aptamer-based and immunosorbents | |
Elhamili et al. | Rapid capillary electrophoresis time‐of‐flight mass spectrometry separations of peptides and proteins using a monoquaternarized piperazine compound (M7C4I) for capillary coatings | |
Krivitsky et al. | Ultrafast and controlled capturing, loading, and release of extracellular vesicles by a portable microstructured electrochemical fluidic device | |
Zheng et al. | Enrichment of IgG and HRP glycoprotein by dipeptide-based polymeric material | |
EP2833143A1 (en) | Method for producing reagent for antibody detection and use thereof | |
CN101913278A (en) | Preparation method of polydopamine-g-polyethylene oxide capillary coating for protein separation by capillary electrophoresis | |
CN116514115A (en) | A kind of graphene oxide material modified with mercaptonicotinic acid and gold nanoparticles and its preparation method and application | |
JP2011149934A (en) | Method for analyzing hemoglobin by electrophoresis | |
Najem et al. | Multifunctional, micropipette-based method for incorporation and stimulation of bacterial mechanosensitive ion channels in droplet interface bilayers | |
Huang et al. | Application of carbon nanotube-matrix assistant native polyacrylamide gel electrophoresis to the separation of apolipoprotein AI and complement C3 | |
Lindén et al. | Characterization of phosphatidylcholine/polyethylene glycol‐lipid aggregates and their use as coatings and carriers in capillary electrophoresis | |
JP2013532825A (en) | Covalent immobilization of molecules containing amino groups | |
Pearlstein et al. | Subpopulations of human serum very low density lipoproteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100623 |